Octreotide in Palliative Treatment of Hepatic Metastases: Is it Effective for Clinical Stabilization?
Authors: Kiki Pistevou-Gompaki, Nikos Eleftheriadis, Damianos Eleftheriadis, Christos Papaloukas and Apostolos Hatzitolios
Publication Date: 13 May 2008
Clinical Medicine: Oncology 2008:2 401-403
Kiki Pistevou-Gompaki1, Nikos Eleftheriadis2, Damianos Eleftheriadis1, Christos Papaloukas1 and Apostolos Hatzitolios2
1Department of Radiation Oncology and 21st Propedeutic Department of Internal Medicine, Aristotle’s University of Thessaloniki, Greece.
Download this full text open access article
Send to Endnote
(232.61 KB PDF format)
Readers of this also read:
- Octreotide in Palliative Treatment of Hepatic Metastases: Is it Effective for Clinical Stabilization?
- Octreotide in Palliative Treatment of Unresectable Cholangiocarcinoma: Is it Effective for Disease Stabilization?
- Pancreas Cancer Survival in the Gemcitabine Era
- Unusual Malignant Transformation of Recurrent Sebaceoma. A Case Report
- Primary Osteosarcoma of the Right Heart Ventricle and Atrium; a Case Report
